BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3251425)

  • 1. [Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
    Tanimura H; Aoki Y; Uesaka K; Kasano Y; Nakai T; Kitamura T; Mukaihara S; Tamura K; Yotsumoto F; Terao R
    Nihon Geka Hokan; 1988 Sep; 57(5):381-99. PubMed ID: 3251425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of biliary tract infection (XXXII)--Excretion into bile, tissue level of the gallbladder and clinical effects of norfloxacin for biliary tract infections].
    Tanimura H; Yoshida K; Kobayashi N; Uchiyama K; Usui Y; Nishimura N; Ozawa K; Kitamura T; Izukura K; Tamura H
    Kansenshogaku Zasshi; 1987 Jun; 61(6):681-703. PubMed ID: 3119741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotics in the treatment of biliary tract infections].
    Perkowski H
    Wiad Lek; 1989 Jan; 42(2):101-5. PubMed ID: 2683383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of lomefloxacin in biliary tract infections].
    Ono Y; Kunii O
    Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 7. Gallbladder tissue concentrations, biliary excretion and pharmacokinetics of OPC-17116.
    Tanimura H; Uchiyama K; Kashiwagi H
    Drugs; 1995; 49 Suppl 2():341-3. PubMed ID: 8549355
    [No Abstract]   [Full Text] [Related]  

  • 8. Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis.
    Stein GE; Smith CL; Peloquin CA; Mosher B; Dybas L; Kepros JP
    Ann Pharmacother; 2010; 44(7-8):1346-7. PubMed ID: 20551298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis].
    Sugata F; Ohguri S; Takamura Y; Tominaga S; Iwamura K; Yamada T; Shibata H; Yamada N; Okabe K; Kato Y
    Jpn J Antibiot; 1989 Sep; 42(9):1873-81. PubMed ID: 2810750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
    Abe H; Hirasawa S; Bekki E; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Katoh H; Matsuda S
    Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
    Ober MC; Hoppe-Tichy T; Köninger J; Schunter O; Sonntag HG; Weigand MA; Encke J; Gutt C; Swoboda S
    J Antimicrob Chemother; 2009 Nov; 64(5):1091-5. PubMed ID: 19734170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of NM441, a new quinolone, into human bile and gallbladder tissue.
    Tanimura H; Ishimoto K; Murakami K; Uchiyama K; Iwakura S
    Drugs; 1995; 49 Suppl 2():337-40. PubMed ID: 8549354
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
    Karachalios GN; Nasiopoulou DD; Bourlinou PK; Reppa A
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):555-7. PubMed ID: 8996852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin in the treatment of biliary tract infections.
    Paulet P
    Acta Gastroenterol Belg; 1976; 39(7-8):293-7. PubMed ID: 1015201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infections of the biliary tract].
    Sorice F; Delia S
    Recenti Prog Med; 1979 May; 66(5):460-85. PubMed ID: 394249
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cifran -- clinical effectiveness in the prevention and treatment of infection].
    Datsenko BM; Tamm TI
    Khirurgiia (Mosk); 1994 Nov; (11):34-5. PubMed ID: 7715135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy for biliary tract infection].
    Shimizu K; Shimada K
    Naika; 1967 Aug; 20(2):255-60. PubMed ID: 4871763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriological study of bile from the gallbladder and bile ducts of patients surgically treated for biliary pathology].
    Tejero A; Riofrío P; Aiquel MJ; Brandago M; Toro X
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):565-7. PubMed ID: 2099858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.